Clin Colon Rectal Surg 2016; 29(02): 106-113
DOI: 10.1055/s-0036-1580722
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques

Ramzi M. Helewa
1   Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada
,
Jason Park
2   Section of Surgical Oncology, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
26 May 2016 (online)

Abstract

Locally advanced T4 rectal cancer represents a complex clinical condition that requires a well thought-out treatment plan and expertise from multiple specialists. Paramount in the management of patients with locally advanced rectal cancer are accurate preoperative staging, appropriate application of neoadjuvant and adjuvant treatments, and, above all, the provision of high-quality, complete surgical resection in potentially curable cases. Despite the advanced nature of this disease, extended and multivisceral resections with clear margins have been shown to result in good oncological outcomes and offer patients a real chance of cure. In this article, we describe the assessment, classification, and multimodality treatment of primary locally advanced T4 rectal cancer, with a focus on surgical planning, approaches, and outcomes.

 
  • References

  • 1 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65 (1) 5-29
  • 2 Amshel C, Avital S, Miller A, Sands L, Marchetti F, Hellinger M. T4 rectal cancer: analysis of patient outcome after surgical excision. Am Surg 2005; 71 (11) 901-903 , discussion 904
  • 3 Guillem JG, Chessin DB, Cohen AM , et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241 (5) 829-836 , discussion 836–838
  • 4 Sauer R, Becker H, Hohenberger W , et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEngl J Med 2004; 351 (17) 1731-1740
  • 5 Edge SB , American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York; London: Springer; 2010
  • 6 Beyond TMEC ; Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg 2013; 100 (8) 1009-1014
  • 7 Sanfilippo NJ, Crane CH, Skibber J , et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J RadiatOncolBiol Phys 2001; 51 (1) 176-183
  • 8 Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia-Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum 2001; 44 (11) 1676-1681
  • 9 de Wilt JH, Vermaas M, Ferenschild FT, Verhoef C. Management of locally advanced primary and recurrent rectal cancer. Clin Colon Rectal Surg 2007; 20 (3) 255-263
  • 10 Park J, Guillem J. T4 and recurrent rectal cancer. In: Czito BG, Willett CG, , eds. Rectal Cancer International Perspectives on Multimodality Management. New York: Humana; 2010: 109-121
  • 11 Tjandra JJ, Kilkenny JW, Buie WD , et al; Standards Practice Task Force; American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48 (3) 411-423
  • 12 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Rectal Cancer. http://www.nccn.org . Accessed January 12, 2015
  • 13 Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000; 15 (1) 9-20
  • 14 Moreno CC, Sullivan PS, Kalb BT , et al. Magnetic resonance imaging of rectal cancer: staging and restaging evaluation. Abdom Imaging 2015; 40 (7) 2613-2629
  • 15 Borowski DW, Bradburn DM, Mills SJ , et al; Northern Region Colorectal Cancer Audit Group (NORCCAG). Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg 2010; 97 (9) 1416-1430
  • 16 Schrag D, Panageas KS, Riedel E , et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002; 236 (5) 583-592
  • 17 Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. SurgGynecol Obstet 1993; 177 (5) 481-487
  • 18 Moore HG, Shoup M, Riedel E , et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47 (10) 1599-1606
  • 19 Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol 2010; 17 (5) 1343-1356
  • 20 Park J, Neuman HB, Weiser MR, Wong WD. Randomized clinical trials in rectal and anal cancers. SurgOncolClin N Am 2010; 19 (1) 205-223
  • 21 Fang CB, Gomes CM, Formiga FB, Fonseca VA, Carvalho MP, Klug WA. Is the delayed surgery after neoadjuvant chemoradiation beneficial for locally advanced rectal cancer?. Arq Bras Cir Dig 2013; 26 (1) 31-35
  • 22 Habr-Gama A, Perez RO, Nadalin W , et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9 (1) 90-99 , discussion 99–101
  • 23 Rödel C, Trojan J, Bechstein WO, Woeste G. Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?. Dig Dis 2012; 30 (Suppl. 02) 102-108
  • 24 Cercek A, Goodman KA, Hajj C , et al. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl ComprCanc Netw 2014; 12 (4) 513-519
  • 25 Fernández-Martos C, Pericay C, Aparicio J , et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 2010; 28 (5) 859-865
  • 26 Habr-Gama A, Perez RO, Proscurshim I , et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?. Int J RadiatOncolBiol Phys 2008; 71 (4) 1181-1188
  • 27 Foster JD, Jones EL, Falk S, Cooper EJ, Francis NK. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Dis Colon Rectum 2013; 56 (7) 921-930
  • 28 Kuo LJ, Chern MC, Tsou MH , et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005; 48 (1) 23-28
  • 29 De Nardi P, Carvello M. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?. World J Gastroenterol 2013; 19 (36) 5964-5972
  • 30 Hendren S, Hammond K, Glasgow SC , et al. Clinical practice guidelines for ostomy surgery. Dis Colon Rectum 2015; 58 (4) 375-387
  • 31 Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002; 235 (2) 217-225
  • 32 Mañas MJ, Espín E, López-Cano M, Vallribera F, Armengol-Carrasco M. Multivisceralresection for locally advanced rectal cancer: prognostic factors influencing outcome. Scand J Surg 2015; 104 (3) 154-160
  • 33 Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 2006; 13 (5) 612-623
  • 34 Suzuki K, Dozois RR, Devine RM , et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39 (7) 730-736
  • 35 Georgiou PA, Tekkis PP, Constantinides VA , et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 2013; 49 (1) 72-81
  • 36 Kim KY, Hwang DW, Park YK, Lee HS. A single surgeon's experience with 54 consecutive cases of multivisceral resection for locally advanced primary colorectal cancer: can the laparoscopic approach be performed safely?. Surg Endosc 2012; 26 (2) 493-500
  • 37 Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979; 22 (3) 277-281
  • 38 Nelson H, Petrelli N, Carlin A , et al; National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93 (8) 583-596
  • 39 Delacroix Jr SE, Winters JC. Bladder reconstruction and diversion during colorectal surgery. Clin Colon Rectal Surg 2010; 23 (2) 113-118
  • 40 Colombo R, Naspro R. Ileal conduit as the standard for urinary diversion after radical cystectomy for bladder cancer. Eur Urol Suppl 2010; 9 (10) 736-744
  • 41 Saito N, Suzuki T, Sugito M , et al. Bladder-sparing extended resection of locally advanced rectal cancer involving the prostate and seminal vesicles. Surg Today 2007; 37 (10) 845-852
  • 42 Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004; 47 (12) 2047-2053 , discussion 2053–2054
  • 43 Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. SurgOncolClin N Am 2005; 14 (2) 225-238
  • 44 Dozois EJ, Privitera A, Holubar SD , et al. High sacrectomy for locally recurrent rectal cancer: can long-term survival be achieved?. J Surg Oncol 2011; 103 (2) 105-109
  • 45 Bhangu A, Brown G, Akmal M, Tekkis P. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer. Br J Surg 2012; 99 (10) 1453-1461
  • 46 Smith JD, Paty PB. Extended surgery and pelvic exenteration for locally advanced rectal cancer. What are the limits?. ActaChir Iugosl 2010; 57 (3) 23-27
  • 47 Han JG, Wang ZJ, Wei GH, Gao ZG, Yang Y, Zhao BC. Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer. Am J Surg 2012; 204 (3) 274-282
  • 48 Alberda WJ, Verhoef C, Nuyttens JJ , et al. Intraoperative radiation therapy reduces local recurrence rates in patients with microscopically involved circumferential resection margins after resection of locally advanced rectal cancer. Int J RadiatOncolBiol Phys 2014; 88 (5) 1032-1040
  • 49 Alektiar KM, Zelefsky MJ, Paty PB , et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J RadiatOncolBiol Phys 2000; 48 (1) 219-226
  • 50 Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum 2005; 48 (3) 438-443
  • 51 Kim J. Pelvic exenteration: surgical approaches. J Korean Soc Coloproctol 2012; 28 (6) 286-293
  • 52 Touny A, Othman H, Maamoon S, Ramzy S, Elmarakby H. Perineal reconstruction using pedicled vertical rectus abdominis myocutaneous flap (VRAM). J Surg Oncol 2014; 110 (6) 752-757
  • 53 Butler CE, Gündeslioglu AO, Rodriguez-Bigas MA. Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg 2008; 206 (4) 694-703
  • 54 Mohan HM, Evans MD, Larkin JO, Beynon J, Winter DC. Multivisceral resection in colorectal cancer: a systematic review. Ann SurgOncol 2013; 20 (9) 2929-2936
  • 55 Bonfanti G, Bozzetti F, Doci R , et al. Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg 1982; 69 (6) 305-307
  • 56 Moriya Y, Akasu T, Fujita S, Yamamoto S. Aggressive surgical treatment for patients with T4 rectal cancer. Colorectal Dis 2003; 5 (5) 427-431
  • 57 Wright FC, Crooks D, Fitch M , et al. Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 2006; 93 (2) 92-99
  • 58 Park J, Neuman HB, Bennett AV , et al. Patient expectations of functional outcomes after rectal cancer surgery: a qualitative study. Dis Colon Rectum 2014; 57 (2) 151-157